Skip to main content

Advertisement

SpringerLink
Log in

Central nervous system coccidioides immitis infections

  • Published:
Current Treatment Options in Neurology Aims and scope Submit manuscript

Opinion statement

Coccidioidal meningitis occurs in healthy individuals and patients with AIDS or other immunosuppressive illnesses. The central nervous system infection results when Coccidioides immitis disseminates from a primary lung infection via a fungemia to reach the meninges. Cases develop primarily in individuals living in or traveling to the Lower Sonoran Life Zone of Southwest United States. Most cases begin as subacute granulomatous meningitis with occasional patients developing brain abscesses. Diagnosis may be challenging because C. immitis is isolated from cerebrospinal fluid in less than 50% of patients. However, a cerebrospinal fluid complement fixation test for IgG antibody to C. immitis has high sensitivity and specificity. Currently, optimal treatment is unclear. Standard therapy has been with life-long oral fluconazole or intrathecal amphotericin B followed by prolonged oral fluconazole. Liposomal amphotericin B given intravenously seems promising as an initial treatment as it has much higher brain penetration, less nephrotoxicity, and less severe infusion-related adverse effects than conventional amphotericin B. However, current comparative studies for efficacy of liposomal amphotericin B in coccidioidal meningitis are lacking.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Stevens DA: Coccidioidomycosis. N Engl J Med 2000, 332:1077–1082. This is an excellent review of coccidioidomycosis.

    Article  Google Scholar 

  2. Chiller TM, Galgiani JN, Stevens DA: Coccidioidomycosis. Infect Dis Clin N Am 2003, 17:41–57. This is an excellent review of coccidioidomycosis.

    Article  Google Scholar 

  3. Vaz A, Pineda-Roman M, Thomas AR, Carlson RW: Coccidioidomycosis: an update. Hosp Pract 1998, 33:105–108, 113–115, 120.

    Article  CAS  Google Scholar 

  4. McGahan JP, Graves DS, Palmer PES, et al.: Classic and contemporary imaging of coccidioidomycosis. AJR 1981, 136:393–404.

    PubMed  CAS  Google Scholar 

  5. Powderly WG: Fungal infections in patients with AIDS. Current Treatment Options in Infectious Diseases 2001, 3:515–522.

    Google Scholar 

  6. Bouza E, Dreyer JS, Hewitt WL, Meyer RD: Coccidioidal meningitis: an analysis of thirty-one cases and review of the literature. Medicine 1981, 60:139–172.

    Article  PubMed  CAS  Google Scholar 

  7. Vincent T, Galgiani JN, Huppert M, Salkin D: The natural history of coccidioidal meningitis: VA-Armed Forces cooperative studies, 1955–1958. Clin Infect Dis 1993, 16:247–254.

    PubMed  CAS  Google Scholar 

  8. Mischel PS, Vinters HV: Coccidioidomycosis of the central nervous system: Neuropathological and vasculopathic manifestations and clinical correlates. Clin Infect Dis 1995, 20:400–405.

    PubMed  CAS  Google Scholar 

  9. Saitoh A, Homans J, Kovacs A: Fluoconazole treatment of coccidioidal meningitis in children: two case reports and a review of the literature. Pediatr Infect Dis J 2000, 19:1204–1208.

    Article  PubMed  CAS  Google Scholar 

  10. Banuelos AF, Williams PL, Johnson RH, et al.: Central nervous system abscesses due to Coccidioides species. Clin Infect Dis 1996, 22:240–250.

    PubMed  CAS  Google Scholar 

  11. Erley WK, Bellon RJ, Seerer JF, Carmody RF: MR imaging of acute coccidioidal meningitis. AJNR Am J Neuroradiol 1999, 20:509–514.

    Google Scholar 

  12. Smith CE, Saito MT, Simons SA: Patterns of 39,500 serologic tests in coccidioidomycosis. JAMA 1956, 160:546–552.

    CAS  Google Scholar 

  13. Ragland AS, Arsura E, Ismail Y, Johnson R: Eosinophilic pleocytosis in coccidioidal meningitis: frequency and significance. Am J Med 1993, 95:254–257.

    Article  PubMed  CAS  Google Scholar 

  14. Stevens DA: Diagnosis of fungal infections: current status. J Antimicrob Chemother 2002, 49(suppl S1):11–19.

    PubMed  CAS  Google Scholar 

  15. McNeil MM, Ampel NM: Opportunistic coccidioidomycosis in patients with human immunodeficiency virus: prevention issues and priorities. Clin Infect Dis 1995, 21(suppl 1):S111–113.

    PubMed  Google Scholar 

  16. Labadie EL, Hamilton RH: Survival improvement in coccidioidal meningitis by high-dose intrathecal amphotericin B. Arch Intern Med 1986, 146:2013–2018. This study showed increased survival with intrathecal amphotericin B.

    Article  PubMed  CAS  Google Scholar 

  17. Galgiani JN, Catanzaro A, Cloud GA, et al.: Fluconazole therapy for coccidioidal meningitis. Ann Intern Med 1993, 119:28–35. This key paper that showed fluconazole rather than amphotericin B could successfully treat coccidioidal meningitis.

    PubMed  CAS  Google Scholar 

  18. Herbrecht R, Natarajan-Ame S, Nivoix Y, Letscher-Bru V: The lipid formulations of amphotericin B. Expert Opin 2003, 4:1277–1287.

    Article  CAS  Google Scholar 

  19. Dupont B: Overview of the lipid formulations of amphotericin B. J Antimicrob Chemother 2002, 49(suppl 1):31–36. This is a good review of the lipid amphotericin B drugs approved by FDA.

    PubMed  CAS  Google Scholar 

  20. Clemons KV, Sobel RA, Williams PL, et al.: Efficacy of intravenous liposomal amphotericin B (AmBisome) against coccidioidal meningitis in rabbits. Antimicrob Agents Chemother 2002, 46:2420–2426.

    Article  PubMed  CAS  Google Scholar 

  21. Galgiani JN, Ampel NM, Cantanzaro A, Johnson RH, Stevens DA, Williams PL: Practice guidelines for treatment of coccidioidomycosis. Clin Infect Dis 2000, 30:658–661. This article features the Guidelines from the Infectious Diseases Society of America.

    Article  PubMed  CAS  Google Scholar 

  22. Terrell CL: Antifungal agents. Part II. The Azoles. Mayo Clin Proc 1999, 74:78–100.

    Article  PubMed  CAS  Google Scholar 

  23. Groll AH, Gea-Banacloche JC, Glasmacher A, et al.: Clinical pharmacology of antifungal compounds. Infect Dis N Am 2003, 17:159–191.

    Article  Google Scholar 

  24. Tucker RM, Denning DW, Dupont B, Stevens DA: Itraconazole therapy for chronic coccidioidal meningitis. Ann Intern Med 1990, 112:108–112.

    PubMed  CAS  Google Scholar 

  25. Tucker RM, Galgiani JN, Denning DW, et al.: Treatment of coccidioidal meningitis with fluconazole. Rev Infect Dis 1990, 12(suppl 3):S380–389.

    PubMed  Google Scholar 

  26. Dewsnup DH, Galgiani JN, Graybill R, et al.: Is it ever safe to stop azole therapy for Coccidioides immitis meningitis? Ann Intern Med 1996, 124:305–310. The authors argue that fluconazole never cures coccidioidal meningitis but only suppresses the infection so life-long maintenance therapy is required.

    PubMed  CAS  Google Scholar 

  27. Kelly PC, Sievers MI, Thompson R, Echols C: Coccidioidal meningitis: results of treatment in 22 patients. In Coccidioidiomycosis: Current Clinical and Diagnostic Status. Edited by Ajello L. Miami: Symposia Specialists; 1977:239–251.

    Google Scholar 

  28. Perez JA, Johnson RH, Caldwell JW, et al.: Fluconazole therapy in coccidioidal meningitis maintained with intrathecal amphotericin B. Arch Intern Med 1995, 155:1665–1668.

    Article  PubMed  CAS  Google Scholar 

  29. Stevens DA, Shatsky SA: Intrathecal amphotericin in the management of coccidioidal meningitis. Sem Resp Infect 2001, 16:263–269. This article gives the best instructions on how to administer intrathecal amphotericin B.

    Article  CAS  Google Scholar 

  30. Keane JR: Cisternal puncture complications. Treatment of coccidioidal meningitis with amphotericin B. Calif Med 1973, 119:10–15.

    PubMed  CAS  Google Scholar 

  31. Adler-Moore J, Proffitt RT: Effect of tissue penetration on AmBisome efficacy. Curr Opin Invest Drug 2003, 4:179–185.

    CAS  Google Scholar 

  32. Dismukes WE: Introduction to antifungal drugs. Clin Infect Dis 2000, 30:653–657.

    Article  PubMed  CAS  Google Scholar 

  33. Romero JH, Rice LB, McQuarrie IG: Hydrocephalus in coccidioidal meningitis: case report and review of the literature. Neurosurgery 2000, 47:773–777.

    Article  Google Scholar 

  34. Davis LE, Cook G, Costerton JW: Biofilm on ventriculoperitoneal shunt tubing as a cause of treatment failure in coccidioidal meningitis. Emerg Infect Dis 2002, 8:376–379.

    Article  PubMed  Google Scholar 

  35. Diamond RD, Bennett JE: A subcutaneous reservoir for intrathecal therapy of fungal meningitis. N Engl J Med 1973, 288:186–188.

    Article  PubMed  CAS  Google Scholar 

  36. Albanese A, Hindmarsh, Stanhope R: Management of hyponatraemia in patients with acute cerebral insults. Arch Dis Child 2001, 85:246–251.

    Article  PubMed  CAS  Google Scholar 

  37. Jeu LA, Piacenti FJ, Lyakhovetskiy AG, Fung HB: Voriconazole. Clin Ther 2003, 25:1321–1381.

    Article  PubMed  CAS  Google Scholar 

  38. Cortez KJ, Walsh TJ, Bennett JE: Successful treatment of coccidioidal meningitis with voriconazole. Clin Infect Dis 2003, 36:1619–1622.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Neurology Service, New Mexico VA Health Care System, 1501 San Pedro Drive SE, 87108, Albuquerque, NM, USA

    Larry E. Davis MD

Authors
  1. Larry E. Davis MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Beth S. Porter MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Davis, L.E., Porter, B.S. Central nervous system coccidioides immitis infections. Curr Treat Options Neurol 7, 157–165 (2005). https://doi.org/10.1007/s11940-005-0025-z

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11940-005-0025-z

Keywords

Search

Navigation